Photophysical evaluation of mTHPC-loaded HSA nanoparticles as novel PDT delivery systems.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Photochemistry and Photobiology. B: Biology

• Publication date

  2010-12-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jphotobiol.2010.08.006PMID 20813540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The present.

  2010influential reference
• Novel photosensitizer-protein nanoparticles for photodynamic therapy: photophysical characterization and in vitro investigations.

  2009cited by this paper
• A new benchmark for time-resolved detection of singlet oxygen luminescence – revealing the evolution of lifetime in living cells with low dose illumination

  2009cited by this paper
• Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.

  2008cited by this paper
• Photoinduced energy and electron transfer processes in hexapyropheophorbide a- fullerene [C(60)] molecular systems.

  2007cited by this paper
• Synthesis and photophysical properties of annulated dinuclear and trinuclear phthalocyanines.

  2006cited by this paper
• Fullerene-pyropheophorbide a complexes as sensitizer for photodynamic therapy: uptake and photo-induced cytotoxicity on Jurkat cells.

  2005cited by this paper
• Interaction of Pheophorbide a molecules covalently linked to DAB dendrimers

  2005cited by this paper
• Trap formation and energy transfer in the hexapyropheophorbide a : fullerene C60 hexaadduct molecular system

  2005cited by this paper
• Serum albumin

  2005cited by this paper
• The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.

  2005cited by this paper
• Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.

  2005cited by this paper
• The present and future role of photodynamic therapy in cancer treatment.

  2004cited by this paper
• mTHPC‐mediated photodynamic therapy for early oral squamous cell carcinoma

  2004cited by this paper
• Optimization of the preparation process for human serum albumin (HSA) nanoparticles.

  2003cited by this paper
• Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck.

  2003cited by this paper
• Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid.

  2000cited by this paper
• Time-resolved detection of singlet oxygen luminescence in red-cell ghost suspensions: concerning a signal component that can be attributed to 1O2 luminescence from the inside of a native membrane.

  1997cited by this paper
• Excited states and free radicals in biology and medicine: edited by R.V. Bensasson, E.J. Land and T.G. Truscott, Oxford University Press, 1993

  1995cited by this paper
• All About Albumin: Biochemistry, Genetics, and Medical Applications

  1995cited by this paper
• Structure of serum albumin.

  1994cited by this paper
• Photodynamic therapy.

  1993influential reference
• HOW DOES PHOTODYNAMIC THERAPY WORK?

  1992cited by this paper
• Atomic structure and chemistry of human serum albumin

  1992cited by this paper
• PHOTOREACTIONS OF MACROCYCLIC DYES BOUND TO HUMAN SERUM ALBUMIN

  1990cited by this paper
• Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers.

  1989influential reference
• Photodynamic Therapy

  1988cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper
• Serum albumin.

  1985cited by this paper
• LIFETIME OF OXYGEN (O2(1ΔG)) IN LIQUID WATER AS DETERMINED BY TIME‐RESOLVED INFRARED LUMINESCENCE MEASUREMENTS

  1983cited by this paper
• Lifetime of oxygen (O2(1.DELTA.g)) in liquid water as determined by time-resolved infrared luminescence measurements

  1982cited by this paper
• Deuterium effects on singlet oxygen lifetimes in solutions. New test of singlet oxygen reactions

  1972cited by this paper
• Atomic Structure

  1921cited by this paper

• Photochemical Properties of Polyfluoroalkylated Chlorin in a Perfluorocarbon Nanoemulsion

  2023cites this paper
• Novel Foscan®-derived ring-fused chlorins for photodynamic therapy of cancer.

  2023cites this paper
• The Photosensitizer Temoporfin (mTHPC) – Chemical, Pre‐clinical and Clinical Developments in the Last Decade † ‡

  2022cites this paper
• Nanotherapeutic Intervention in Photodynamic Therapy for Cancer

  2022cites this paper
• Measuring the concentration of protein nanoparticles synthesized by desolvation method: comparison of Bradford assay, BCA assay, hydrolysis/UV spectroscopy and gravimetric analysis.

  2020cites this paper
• New Targeted Gold Nanorods for the Treatment of Glioblastoma by Photodynamic Therapy

  2019cites this paper
• Current state of the nanoscale delivery systems for temoporfin-based photodynamic therapy: Advanced delivery strategies.

  2019cites this paper
• Improvement in dissolution rate and photodynamic efficacy of chlorin e6 by sucrose esters as drug carrier in nanosuspension formulation: optimisation and in vitro characterisation

  2018cites this paper
• Targeting integrin-rich tumors with temoporfin-loaded vitamin-E-succinate-grafted chitosan oligosaccharide/d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles to enhance photodynamic therapy efficiency.

  2017cites this paper
• Albumin based versatile multifunctional nanocarriers for cancer therapy: Fabrication, surface modification, multimodal therapeutics and imaging approaches.

  2017cites this paper
• The alteration of temoporfin distribution in multicellular tumor spheroids by β-cyclodextrins.

  2017cites this paper
• Self‐Assembled Peptide‐ and Protein‐Based Nanomaterials for Antitumor Photodynamic and Photothermal Therapy

  2017cites this paper
• Synthesis, Photophysics and PDT Evaluation of Mono‐, Di‐, Tri‐ and Hexa‐PEG Chlorins for Pointsource Photodynamic Therapy

  2017cites this paper
• Drug Carrier for Photodynamic Cancer Therapy

  2015influential citation
• Nanoparticulate carriers for photodynamic therapy of cholangiocarcinoma: In vitro comparison of various polymer-based nanoparticles.

  2015cites this paper
• Nanocarriers for photodynamic therapy-rational formulation design and medium-scale manufacture.

  2015cites this paper
• Chlorin e6 combined with albumin nanoparticles as a potential composite photosensitizer for photodynamic therapy of tumors.

  2015cites this paper
• From thioether substituted porphyrins to sulfur linked porphyrin dimers: an unusual SNAr via thiolate displacement?

  2014cites this paper
• Quantum chemistry studies of meta-tetra(hydroxyphenyl) chlorin (mTHPC) and its isomers

  2014cites this paper
• A novel chlorin-PEG-folate conjugate with higher water solubility, lower cytotoxicity, better tumor targeting and photodynamic activity.

  2013cites this paper
• Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology.

  2013cites this paper
• Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges.

  2013cites this paper
• Enhanced Tumor Targeting and Photocytotoxicity of Folate–Poly(ethylene glycol)–Chlorin Photosensitizer Mediated by Folate Receptor

  2013cites this paper
• Interaction between hemoglobin A and merocyanine 540: A spectroscopic investigation supported by docking

  2013cites this paper
• Photophysical origin of the reduced photodynamic therapy activity of temocene compared to Foscan®: insights from theory.

  2013cites this paper
• Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan® and Fospeg in a human prostate cancer cell line.

  2012cites this paper
• Non polymeric nanoparticles for photodynamic therapy applications: recent developments.

  2012cites this paper
• Photodynamic therapy as novel nephron sparing treatment option for small renal masses.

  2012cites this paper
• Binding of fullerol to human serum albumin: spectroscopic and electrochemical approach.

  2012cites this paper
• New aspects in singlet oxygen luminescence detection in biological relevant systems

  2011cites this paper
• Photosensitizer loaded HSA nanoparticles II: in vitro investigations.

  2011cites this paper
• Temocene: The porphycene analogue of temoporfin (Foscan®)

  2011cites this paper
• Photophysical characterization and optimization of novel polymer based photosensitizer carrier systems for PDT

  2010cites this paper